Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Complementary and Integrative Interventions

Aug 30, 2018/Policies & Bylaws

House position: Describes APTA's role in supporting the continued use of evidence-based complementary and integrative interventions in physical therapist practice.

Guidelines: Recruiting and Hiring Internationally Educated Physical Therapists

Aug 13, 2020/Policies & Bylaws

House guideline: Outlines the process to recruit and hire internationally-educated physical therapists.

Impaired Colleagues and Providers

Sep 20, 2019/Policies & Bylaws

House position: Outlines expectations for members when addressing problems demonstrated by impaired colleagues and providers.

Commitment to Interprofessional Education and Practice

Sep 23, 2024/Policies & Bylaws

Ammended to: The Association supports interprofessional education and practice.

Family-forward Organizational Policies and Programs For Physical Therapy Employers

Jul 22, 2024/Policies & Bylaws

House policy: Describes the association's commitment to being a family-forward organization.

Movement Screen

May 22, 2024/Resource

The movement screen is a tool designed to detect movement impairments observed during functional tasks and activities that will help you decide which additional tests and measures to include in the patient and client examination.

APTA Advertiser, Exhibitor, and Sponsor Opportunities

Extend your business and brand to more than 100,000 APTA members.

Vulnerability and Courage

Jun 1, 2020/Column

For PTs and PTAs, the two never have been more closely intertwined.

Fibromyalgia: Diagnosis and Management

Feb 1, 2023/CPG

This guideline from the American Academy of Family Physicians provides clinical recommendations related to diagnosis, treatment approach, interventions, and medication.

Advanced Breast Cancer: Diagnosis and Treatment (Updated) [NICE CG81]

Feb 19, 2025/CPG

This guideline provides recommendations related to the diagnosis and treatment of patients with advanced breast cancer.